Guidelines for Antibiotic Use in Pediatric Patients
Antibiotic selection for pediatric patients should be based on the specific infection site, severity of illness, and local resistance patterns, with narrow-spectrum agents preferred whenever possible to minimize antimicrobial resistance.
Respiratory Tract Infections
Bronchitis and Pneumonia
First-line treatment for bacterial bronchitis/pneumonia:
Alternative options:
Duration of treatment:
Bronchiolitis
- Primarily viral - antibiotics not routinely recommended unless bacterial co-infection suspected 1
Intra-abdominal Infections
Empiric Therapy Options
Aminoglycoside-based regimen:
- Amikacin: 15-22.5 mg/kg/day every 8-24h
- Gentamicin: 3-7.5 mg/kg/day every 8-24h
- Tobramycin: 3.0-7.5 mg/kg/day every 8-24h 2
Carbapenems:
- Ertapenem: 15 mg/kg twice daily (≤12 years), 1 g/day (≥13 years)
- Imipenem-cilastatin: 60-100 mg/kg/day every 6h
- Meropenem: 60 mg/kg/day every 8h 2
Beta-lactam/beta-lactamase inhibitors:
- Piperacillin-tazobactam: 200-300 mg/kg/day of piperacillin component every 6-8h
- Ticarcillin-clavulanate: 200-300 mg/kg/day of ticarcillin component every 4-6h 2
Cephalosporins with metronidazole:
- Cefotaxime: 150-200 mg/kg/day every 6-8h
- Ceftriaxone: 50-75 mg/kg/day every 12-24h
- Ceftazidime: 150 mg/kg/day every 8h
- Cefepime: 100 mg/kg/day every 12h
- Metronidazole: 30-40 mg/kg/day every 8h 2
Special Considerations
- For severe beta-lactam allergies: ciprofloxacin (20-30 mg/kg/day every 12h) plus metronidazole or aminoglycoside-based regimen 2
- Necrotizing enterocolitis in neonates: ampicillin, gentamicin, and metronidazole; or ampicillin, cefotaxime, and metronidazole; or meropenem 2
Skin and Soft Tissue Infections
Mild Infections
- First-line options:
- Amoxicillin-clavulanic acid
- Cloxacillin
- Cefalexin 2
Necrotizing Fasciitis
- Recommended regimens:
- Clindamycin + piperacillin-tazobactam (with or without vancomycin)
- Ceftriaxone + metronidazole (with or without vancomycin) 2
Urinary Tract Infections
Neonates (<28 days)
- Hospitalization with parenteral amoxicillin and cefotaxime
- Complete 14 days total therapy (transition to oral after clinical improvement) 3
Infants (28 days to 3 months)
- Clinically ill: Hospitalize with parenteral 3rd generation cephalosporin or gentamicin
- Not acutely ill: Outpatient management with daily ceftriaxone or gentamicin until afebrile
- Complete 14 days total therapy 3
Children with Pyelonephritis
- Complicated: Hospitalize with parenteral ceftriaxone or gentamicin until improved
- Uncomplicated: Outpatient parenteral ceftriaxone or gentamicin until afebrile
- Complete 10-14 days total therapy 3
Children with Cystitis
- Oral antibiotics for 5-7 days 3
Dosing Considerations
Amoxicillin Dosing
For children <40 kg:
- Mild/moderate infections: 25 mg/kg/day divided every 12h or 20 mg/kg/day divided every 8h
- Severe infections: 45 mg/kg/day divided every 12h or 40 mg/kg/day divided every 8h 4
For children <12 weeks:
- Maximum 30 mg/kg/day divided every 12h due to immature renal function 4
Clindamycin Dosing
- Serious infections: 8-16 mg/kg/day divided into 3-4 equal doses
- Severe infections: 16-20 mg/kg/day divided into 3-4 equal doses 5
- For beta-hemolytic streptococcal infections: minimum 10-day treatment 5
Key Principles for Antibiotic Use
- Appropriate selection: Match antibiotic to suspected pathogen and site of infection
- Narrow-spectrum when possible: Avoid broad-spectrum agents when narrow-spectrum options are effective 1
- Appropriate duration: Treat for recommended duration based on infection type and severity
- Monitoring: Assess clinical improvement within 48-72 hours; consider changing antibiotics if no improvement 1
- Supportive care: Ensure adequate oxygenation, hydration, and nutrition alongside antibiotic therapy 1
Common Pitfalls to Avoid
- Overuse of broad-spectrum antibiotics: Studies show high rates of azithromycin prescribing (47%) for pediatric pneumonia despite guidelines recommending amoxicillin 6
- Unnecessary antibiotic exposure: One study found 46.4% of children received antibiotics for suspected UTI despite negative cultures 7
- Inappropriate dosing: This is a common reason for non-adherence to guidelines 8
- Regional prescribing variations: Significant differences in amoxicillin prescribing exist between regions, with lower rates in the Midwest and South compared to the Northeast 6
- Failure to adjust therapy based on culture results: Implement processes to discontinue antibiotics for negative cultures 7
By following these evidence-based guidelines and avoiding common pitfalls, clinicians can optimize antibiotic therapy for pediatric patients while minimizing unnecessary antibiotic exposure and resistance development.